Inappropriate prescribing of antimalarial therapy for the treatment of undifferentiated febrile illness among the elderly-Reference-Cited by-同舟云学术

Inappropriate prescribing of antimalarial therapy for the treatment of undifferentiated febrile illness among the elderly

Published:2018-12 Issue:6 Volume:48 Page:530-536
ISSN:1445-937X
Container-title:Journal of Pharmacy Practice and Research
language:en
Short-container-title:J Pharm Pract Res

Author:

Menon Vineetha Bharathan¹²,Ramesh Madhan¹,Pereira Pratibha³,Chilkunda Raviprakash Venkatesh³,Undela Krishna¹

Affiliation:

1. Department of Pharmacy Practice JSS College of Pharmacy JSS University Mysore India

2. School of Pharmacy Monash University Bandar Sunway Selangor Malaysia

3. Department of Internal Medicine JSS Hospital and Medical College JSS University Mysore India

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jppr.1452

Reference33 articles.

1. A protocol for the emergency department management of acute undifferentiated febrile illness in India

2. BabcockHM FraserVJ.Inappropriate antibiotic use;2003. Available from . Accessed 7 March 2017.

3. Cost implication of irrational prescribing of chloroquine in Lagos State general hospitals

4. National Centre for Disease Control Government of India.National treatment guidelines for antimicrobial use in infectious diseases;2016. Available from . Accessed 7 March 2017.

5. Fever in the Elderly

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost of inappropriate prescriptions for uncomplicated malaria in Ghana;Malaria Journal;2023-05-18

2. Overuse of medications in low- and middle-income countries: a scoping review;Bulletin of the World Health Organization;2023-01-01

3. Cost of Inappropriate Prescriptions for Uncomplicated Malaria in Ghana;2022-10-17

4. The cost-effectiveness of using rapid diagnostic tests for the diagnosis of typhoid fever in patients with suspected typhoid fever: a systematic review;Expert Review of Pharmacoeconomics & Outcomes Research;2021-12-16